LOTUS PHARMACEUTICAL COLOTUS PHARMACEUTICAL COLOTUS PHARMACEUTICAL CO

LOTUS PHARMACEUTICAL CO

No trades
See on Supercharts

Price target

377.220.000.00%
The 9 analysts offering 1 year price forecasts for 1795 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to 1795 in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


1795 EPS for the last quarter is 5.98 TWD despite the estimation of 6.21 TWD. In the next quarter EPS is expected to reach 3.34 TWD. Track more of LOTUS PHARMACEUTICAL CO financials and stay on top of what is up with the company.
In the next quarter LOTUS PHARMACEUTICAL CO revenue is expected to reach ‪4.31 B‬ TWD. Check out LOTUS PHARMACEUTICAL CO revenue and earnings and make informed decisions.
According to analysts, 1795 price target is 377.22 TWD with a max estimate of 600.00 TWD and a min estimate of 330.00 TWD. Check if this forecast comes true in a year, meanwhile watch LOTUS PHARMACEUTICAL CO stock price chart and keep track of the current situation with 1795 news and stock market news.
We've gathered opinions of 9 analysts rating 1795 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.